drugset / Trial / NCT00570908
Brain Mets - Capecitabine Plus Sunitinib and WBRT
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficacy and safety of concurrent whole brain radiotherapy (WBRT) and capecitabine followed by combination capecitabine and sunitinib in treating patients with CNS metastases from breast cancer.
Timeline
- Start
- 2009-02
- Primary completion
- 2013-09
- Completion
- 2013-09
Outcome
Outcome not reported
Stopped (Enrollment): “Due to poor accrual this study is being closed to accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 2000 mg/m2 | — |
| Subject | Sunitinib | Small molecule | 37.5 mg | — |